search

UMD     This Site





Prof. Bruce Jacob

Prof. Bruce Jacob

 

Professor Bruce Jacob was part of a team selected by the Defense Advanced Research Projects Agency (DARPA) to develop new supercomputer prototype systems for DARPA's Ubiquitous High Performance Computing (UHPC) program.

The 4-year, $25.8M award will fund research at the University of Maryland, as well as academic project partners at Louisiana State University, University of Illinois at Urbana-Champaign, University of Notre Dame, University of Southern California, Georgia Institute of Technology, Stanford University and North Carolina State University. Sandia Laboratories, a wholly owned subsidiary of Lockheed Martin company, is leading a team of industry partners on the project, including Micron Technology, Inc. and LexisNexis Special Services, Inc.

The goal of the UHPC program is to overcome current limiting factors, such as power consumption and architectural and programming complexity, by developing entirely new computer architectures and programming models. The program's aim is to produce a more energy-efficient computer that delivers 100 to 1,000 times more performance and is easier to program than current systems.

Other research proposals selected to develop UHPC prototypes came from Intel Corp., NVIDIA Corp. and Massachusetts Institute of Technology Computer Science and Artificial Intelligence Laboratory.

August 22, 2010


«Previous Story  

 

 

Current Headlines

Ingestible Capsule Advances May Lead to Earlier Detection of Diseases

University of Maryland Moves Ahead in Its Leadership of the United States' Semiconductor Industry

Srivastava Named Inaugural Director of Semiconductor Initiatives and Innovation

State-of-the-Art 3D Nanoprinter Now at UMD

UMD, Partners Receive $31M for Semiconductor Research

Two NSF Awards for ECE Alum Michael Zuzak (Ph.D. ’22)

Applications Open for Professor and Chair of UMD's Department of Materials Science and Engineering

Ghodssi Honored With Gaede-Langmuir Award

Milchberg and Wu named Distinguished University Professors

New features on ingestible capsule will deliver targeted drugs to better treat IBD, Crohn’s disease

 
 
Back to top  
Home Clark School Home UMD Home